Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post
Binding Commitments Received for A$1.0 Million under Convertible Note Placement
next post
Yemen’s Houthis claim dozens killed in alleged US airstrike on prison holding African migrants

Related Posts

Uranium Price Update: Q1 2025 in Review

April 24, 2025

Trump Takes Aim at China with Deep-Sea Mining...

April 29, 2025

INSG: Global Nickel Surplus to Hit 198,000 MT...

April 30, 2025

$2.6M Placement and SPP to fast-track China entry...

May 9, 2025

Riverside Resources and Questcorp Mining Execute Definitive Option...

May 6, 2025

Empire Metals: Advancing a Game-changing, Globally Significant Titanium...

May 1, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (41)
    • Investing (143)
    • Stocks (56)
    • World News (182)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved